Empagliflozin Favorably Reshaped LVs in HFrEF Patients ...Middle East

Medscape - News
Treatment with the SGLT2 inhibitor empagliflozin led to significant reductions in both left ventricular end systolic and diastolic volumes in two independent randomized studies of patients with heart failure with reduced ejection fraction. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Empagliflozin Favorably Reshaped LVs in HFrEF Patients )

Apple Storegoogle play

Also on site :